BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12369460)

  • 1. Alteration of membrane polarization by (-)-terpestacin, a biologically active fungal metabolite.
    Grigoriev PA; Schlegel B; Schmidtke M; Gräfe U
    Pharmazie; 2002 Sep; 57(9):653-4. PubMed ID: 12369460
    [No Abstract]   [Full Text] [Related]  

  • 2. Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.
    Oka M; Iimura S; Tenmyo O; Sawada Y; Sugawara M; Ohkusa N; Yamamoto H; Kawano K; Hu SL; Fukagawa Y
    J Antibiot (Tokyo); 1993 Mar; 46(3):367-73. PubMed ID: 8478254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytotoxic sesterterpene, 11-epiterpestacin, from Bipolaris sorokiniana NSDR-011.
    Nihashi Y; Lim CH; Tanaka C; Miyagawa H; Ueno T
    Biosci Biotechnol Biochem; 2002 Mar; 66(3):685-8. PubMed ID: 12005073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of cyclooctatin, a new inhibitor of lysophospholipase.
    Aoyama T; Naganawa H; Muraoka Y; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1703-4. PubMed ID: 1474002
    [No Abstract]   [Full Text] [Related]  

  • 5. Nosporins A and B, new metabolites from a filamentous fungus, VKM-3750.
    Kozlovsky AG; Zhelifonova VP; Adanin VM; Ozerskaya SM; Gräfe U
    Pharmazie; 2003 Jan; 58(1):76-7. PubMed ID: 12622263
    [No Abstract]   [Full Text] [Related]  

  • 6. [The molecular mechanism of the antiviral action of 2-(1'-aminoethyl)-bicyclo (2.2.1) heptane hydrochloride].
    Fedorov AN; El-Karadagi S; Rusiaev VA; Kharitonenkov IG; Tverdislov VA
    Vopr Virusol; 1988; 33(4):403-7. PubMed ID: 3195141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis of (+/-)-terpestacin and (+/-)-11-epi-terpestacin.
    Berger GO; Tius MA
    J Org Chem; 2007 Aug; 72(17):6473-80. PubMed ID: 17630803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first total synthesis of natural (+)-terpestacin, syncytium formation inhibitor.
    Tatsuta K; Masuda N
    J Antibiot (Tokyo); 1998 Jun; 51(6):602-6. PubMed ID: 9711228
    [No Abstract]   [Full Text] [Related]  

  • 9. [The mechanism of membranotropic action of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Belousov AA; Voronkov MG
    Dokl Akad Nauk SSSR; 1989; 306(6):1479-82. PubMed ID: 2553369
    [No Abstract]   [Full Text] [Related]  

  • 10. [An analysis of the possible mechanism of the ulcerostatic action of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Bartkova LK; Suslova SK; Belousov AA; Voronkov MG
    Izv Akad Nauk SSSR Biol; 1991; (4):522-7. PubMed ID: 1787228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of membranotropic effect of methylethyl(silatrane-1-yl methyl) sulfonium iodide].
    Kuznetsov IG; Rasulov MM; Sorokin MS; Suslova SK; Voronkov MG
    Dokl Akad Nauk SSSR; 1988; 301(5):1235-7. PubMed ID: 2852585
    [No Abstract]   [Full Text] [Related]  

  • 12. Curvature-electric effects in artificial and natural membranes studied using patch-clamp techniques.
    Petrov AG; Ramsey RL; Usherwood PN
    Eur Biophys J; 1989; 17(1):13-7. PubMed ID: 2752990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic activity of terpestacin, a bicyclo sesterterpene from Embellisia chlamydospora.
    Jung HJ; Lee HB; Kim CJ; Rho JR; Shin J; Kwon HJ
    J Antibiot (Tokyo); 2003 May; 56(5):492-6. PubMed ID: 12870816
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of new n-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1-acetyldibenzo-[e.h]-bicyclo[2.2.2]-octane-2,3-dicarboximide.
    Kossakowski J; Szczepek W; Pakosińska-Parys M
    Acta Pol Pharm; 2002; 59(6):418-23. PubMed ID: 12669762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of lipid chain attached fluorophore 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) in negatively charged membranes determined by NMR spectroscopy.
    Huster D; Müller P; Arnold K; Herrmann A
    Eur Biophys J; 2003 Mar; 32(1):47-54. PubMed ID: 12632206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of (-)-terpestacin via catalytic, stereoselective fragment coupling: siccanol is terpestacin, not 11-epi-terpestacin.
    Chan J; Jamison TF
    J Am Chem Soc; 2003 Sep; 125(38):11514-5. PubMed ID: 13129351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XVIII. Derivatives of 1-bromo-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide.
    Kossakowski J; Perliński M
    Acta Pol Pharm; 2001; 58(4):257-62. PubMed ID: 11693729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new N-substituted cyclic imides with potential anxiolytic activity. XXV. Derivatives of halogenodibenzo[e.h]bicyclo[2.2.2]octane-2.3-dicarboximide.
    Kossakowski J; Perliński M
    Acta Pol Pharm; 2003; 60(3):183-90. PubMed ID: 14556486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of lantibiotic warnerin on lipid bilayer membranes].
    Borisova MP; Korobov VP; Lemkina LM; Pan'kova NV; Likhatskaia GN
    Biofizika; 2009; 54(3):454-8. PubMed ID: 19569505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of bicozamycin (CGP 3543/E) on different enteropathogenic micro-organisms: comparison with other antimicrobial agents.
    Vanhoof R; Coignau H; Stas G; Goossens H; Butzler JP
    J Antimicrob Chemother; 1982 Oct; 10(4):343-6. PubMed ID: 7142080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.